Charles Ross Expands Operations in China
The equipment company added 30,000 sq. ft of manufacturing space and increased staffing at its facility in Wuxi, China.
Photo © iStockphoto.com/jpa1999
Charles Ross & Son Company (Hauppauge, NY) has expanded its manufacturing operations in China and is already looking to grow further, with additional facility construction expected to begin next year.
The company’s operations in Wuxi, China have added 30,000 square feet of manufacturing space and increased staffing to reach a total of more than 165 full-time employees, according to Joseph Martorana, vice president of corporate operations. The expansion will enable the Wuxi subsidiary of Charles Ross & Son Co. to “more efficiently handle a surge in new orders from various process industries, particularly from Chinese battery producers,” according to a press release.
The company is also looking to expand its Wuxi operation further. Plans are in the works to relocate to a bigger facility, and construction on the new 200,000-sq. ft manufacturing plant is expected to begin in 2016.
There are currently eight Charles Ross & Son Co. production facilities located in the United States, China, and India. The company has manufactured industrial mixing, blending, drying, and dispersion equipment since 1842.
Read more:
China’s New Dietary Supplement Law Goes into Effect in October. But Will It Solve the Problems?
It’s Official! China Redrafting Regulatory Process for Dietary Supplements
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
